Events
Registration now open for first-ever Eyes On Practice Management
Kicking off June 27, virtual event will offer up to 5 hours of COPE-accredited CE credits for attendees looking to explore how to fix operational gaps in their clinics.
Products
CooperVision expands US availability of Biofinity XR toric lenses
Company announces new next-day shipping delivery for domestic inventory along with 1,500 new parameters.
Pipeline
FDA grants TearSolutions' NK peptide therapy two FDA designations
Investigational eye drop acts as a replacement for lacritin by restoring homeostasis to the ocular surface; phase 2 trial initiation is underway.
Research
Illinois Tech researchers report third implant of wireless visual prosthesis
Groundbreaking brain implant highlights new pathway to providing artificial vision for individuals with blindness.
Products
Bausch + Lomb launches Blink Triple Care PF eye drops
Preservative-free lubricant features hyaluronic acid and castor oil to offer a 3-in-1 extended dry eye symptom relief for up to 10 hours.
Research
Should normal-tension glaucoma patients be more closely monitored?
New research suggests certain NTG patients may need closer follow-up due to unstable visual field results.
Pipeline
Oculis's phase 3 DME eye drop trial fails primary goals
While OCS-01 was well-tolerated, the DIAMOND program did not meet either outcome measures; company will not seek an FDA NDA filing.
Business
Visionix and iCare officially merge portfolios
Integration follows after parent company Revenio announced plans to combine both arsenals of ophthalmic medical device and imaging solutions.
Pipeline
Outlook resubmits wet AMD BLA for bevacizumab after FDA appeal win
Marks fourth attempt to secure approval for the potential first on-label bevacizumab product specifically formulated for IVT retinal use in the US.
Business
Leadership watch: Optivate, TVC, Ocuco name new executives
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Business
National Academy of Opticianry and United Opticians Association kick-start potential merger
Announcement follows both organizations’ vote to authorize a formal process last week; next phase involves review by a joint steering committee.
Business
Lexitas acquires Erie Retina Research to expand ophthalmic trials
Partnership also involves integration of CASExERIE and Element Erie: Imaging and Reading Center to establish a fully integrated retina research platform.
Business
NeuroVision expands retinal imaging-based neurodegenerative disease detection with new acquisition
Retinal imaging developer adds Durin Life Sciences’ noninvasive, blood-based biomarker test to its integrated platform targeting cognitive diseases.
Research
Vitreous floaters may predict RD development
Cohort study finds new-onset floaters, particularly when acute or numerous, confer a higher absolute risk of retinal detachment than flashes alone.
Pipeline
Outlook Therapeutics wins FDA appeal for wet AMD BLA
Decision follows company’s challenge to its third rejected package of ONS-5010 / LYTENAVA (bevacizumab-vikg); fourth submission expected in June.
Products
PECAA debuts private label 1-day contact lenses developed by CooperVision
Launching June 1, members will gain access to an exclusive line of CooperVision-made lenses based on the MyDay and Clariti 1-Day DDs.
Research
Low vision rehab less effective in patients with hearing loss
Patients with hearing impairment less likely to achieve clinically meaningful improvement from vision rehabilitation.
Research
Neuvasq highlights novel antibody approach for restoring blood-retina barrier in wet AMD and DME
Preclinical data of NVQ401 and NVQ501 demonstrate improvements in BRB integrity and function in vascular retinopathy models.
Research
Metformin may slow postoperative PCO
Study findings suggest the common diabetes drug may reach the lens capsule and reduce cell activity linked to secondary cataract formation.
Pipeline